Left sidebar

Lorem Ipsum is simply dummy text of the printing.
Posted by The Analyst | 29 June 2020 | Breaking News
Markets boosted as travel firms fly high

US markets seemed detached from the reality on the ground on Monday, as they helped drag their European cousins upwards.

Continue Reading
Posted by The Analyst | 29 June 2020 | Science & Tech
The 5 best Amazon deals you can get this weekend

This weekend, the best Amazon deals are happening on everything from Amazon Fire Sticks to iRobot Roombas and more. Click for details.

Continue Reading
Posted by The Analyst | 29 June 2020 | Breaking News
EU formally extends economic sanctions against Russia for 6 months – European Council

EU member states formally extended economic sanctions against Russia on Monday by six months until January 31 next year, the European Council said on Monday. European leaders had agreed to extend the sanctions at their summit on June 19, after discussing the state of the Minsk agreements aimed at settling the conflict in eastern Ukraine....

Continue Reading
Posted by The Analyst | 29 June 2020 | Foreign Affairs
UK judge says Depp broke court order in Sun libel case

A U.K. High Court judge ruled Monday that actor Johnny Depp violated a court order by failing to disclose evidence relating to his drug use to lawyers for British tabloid … Click to Continue »

Continue Reading
Posted by The Analyst | 29 June 2020 | Politics
Broadway shutdown due to virus extended again until January

The shutdown on Broadway has been extended again — until at least early January. Although an exact date for performances to resume has yet to be determined, Broadway producers are … Click to Continue »

Continue Reading
Posted by The Analyst | 29 June 2020 | Politics
EU finalizing virus ‘safe list,’ US unlikely to make the cut

The European Union is edging toward finalizing a list of countries whose citizens will be allowed to enter Europe again in coming days, with Americans almost certain to be excluded … Click to Continue »

Continue Reading
Posted by The Analyst | 29 June 2020 | Business
US drug maker says its coronavirus medication will cost up to $5,700 per treatment

Gilead Sciences announced pricing plans for its coronavirus-fighting drug remdesivir. It will charge the US government and other developed countries $390 per vial, or about $2,340 for a typical five-day course of treatment. The US biopharmaceutical company said it would offer a one-price model to avoid the need for country-by-country negotiations that could slow down...

Continue Reading